Senior Cell Therapy MSL - Myeloma Expert (PNW)

AstraZeneca GmbH; Seattle (WA); Hybrid; USD 174,000 - 262,000; Full time

Benefits offered by this job

Competitive base salary

Short-term incentives

Health, dental, and vision insurance

Retirement plans

Job summary

AstraZeneca is seeking a Senior Medical Science Liaison (MSL) to lead medical strategy for cell therapy and multiple myeloma in the Pacific Northwest, including Seattle and San Francisco. This field-based role requires building relationships with hematology and cell therapy specialists to advance patient care and AstraZeneca's pipeline.

You will educate provider teams on disease state, CAR-T concepts, manufacturing processes, and safety considerations, while collaborating across Medical Affairs,

Qualifications

• Advanced scientific degree in health science or clinical discipline.
• 5+ years in hematology/oncology with field medical exposure.
• Experience launching or supporting a pharmaceutical product in the US.
• Ability to distill complex concepts into clear messages.

Responsibilities

• Develop and maintain relationships with hematology/cell therapy experts.
• Provide scientific exchange with clinicians, APPs, pharmacists and staff.
• Educate provider teams on disease state, CAR-T, and manufacturing processes.
• Collaborate across Medical Affairs, Commercial and R&D.
• Support medical affairs at congresses and meetings.

Skills

Scientific communication

Stakeholder engagement

Medical affairs knowledge

Cross-functional collaboration

Travel flexibility

Education

MD/DO/PhD/PharmD/PA/NP

Job description

AstraZeneca is seeking a Senior Medical Science Liaison (MSL) to lead medical strategy for cell therapy and multiple myeloma in the Pacific Northwest, including Seattle and San Francisco. This field-based role requires building relationships with hematology and cell therapy specialists to advance patient care and AstraZeneca's pipeline.

You will educate provider teams on disease state, CAR-T concepts, manufacturing processes, and safety considerations, while collaborating across Medical Affairs,